SE8007540L - aminocyclitols - Google Patents

aminocyclitols

Info

Publication number
SE8007540L
SE8007540L SE8007540A SE8007540A SE8007540L SE 8007540 L SE8007540 L SE 8007540L SE 8007540 A SE8007540 A SE 8007540A SE 8007540 A SE8007540 A SE 8007540A SE 8007540 L SE8007540 L SE 8007540L
Authority
SE
Sweden
Prior art keywords
hydrogen
resulting
prepared
hydroxy
dideoxy
Prior art date
Application number
SE8007540A
Other languages
Swedish (sv)
Inventor
S J Daum
Grone Clarke R La
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/550,273 external-priority patent/US3972930A/en
Priority claimed from US05/615,593 external-priority patent/US3982996A/en
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of SE8007540L publication Critical patent/SE8007540L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • C07H15/236Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2 a saccharide radical being substituted by an alkylamino radical in position 3 and by two substituents different from hydrogen in position 4, e.g. gentamicin complex, sisomicin, verdamycin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/58Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in three-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/385Saturated compounds containing a keto group being part of a ring
    • C07C49/487Saturated compounds containing a keto group being part of a ring containing hydroxy groups
    • C07C49/497Saturated compounds containing a keto group being part of a ring containing hydroxy groups a keto group being part of a six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

1529376 Aminocyclitol antibiotics STERLING DRUG Inc 9 Feb 1976 [18 Feb 1975 22 Sept 1975] 04973/76 Heading C2C Novel aminocyclitol antibiotics of the general Formula I wherein R 1 , R 3 and R 8 are hydrogen, or one of R 1 , R 3 and R 8 is H 2 NCH 2 (CH 2 ) n CHOHCO-, wherein n is 0 or 1, and the others are hydrogen; R 2 is H or OH; R 5 is hydrogen, hydroxy or halogen, except that when R 2 is hydrogen, R 5 is not hydroxy cis to the amino groups at the 1- and 3- positions; and R 6 and R 7 are each hydrogen or methyl, and acid addition salts thereof are prepared (a) when R 1 ,R 4 and R 8 are each hydrogen, by culturing a nutrient medium containing carbohydrates, a source of assimilable nitrogen, essential salts and a corresponding aminocyclitol of the general formula wherein R 1 , R 2 , R 3 and R 5 are as defined above, except that R 1 and R 3 may also form a single bond between the nitrogen atoms to which they are attached, in the presence of Micromonospora purpurea ATCC 31,119, and isolating the desired product from the medium; (b) when R 1 , R 3 and R 8 are each hydrogen and R 5 is as defined above with the exception of halogen, by culturing a nutrient medium containing carbohydrates, a source of assimilable nitrogen, essential salts and a cyclitol of the general formula wherein R is hydrogen or acetyl, R1 3 is oxo or hydroxy and R1 2 and R1 5 are each hydrogen or OR, in the presence of Micromonospora purpurea ATCC 31,164; (c) when R 1 , R 3 and R 8 are each hydrogen and R 5 is as defined above with the exception of halogen, by culturing a nutrient medium containing carbohydrates, a source of assimilable nitrogen, essential salts and an aminoclitol of the general formula wherein R1 2 and R1 5 correspond to R 2 and R 5 and R1 1 is amino or hydroxy, in the presence of Micromonospora purpurea 31,164; and (d) when one of R 1 , R 3 and R 8 is by reacting the product of (a), (b) or (c) with an N-hydroxysuccinimide ester of the general formula followed by hydrogenolysis of the resulting N- benzylorycarbonyl derivative with hydrogen and a catalyst; followed optionally by salification of the product. dl-Deoxyinosose is prepared by microbiological oxidation of dl-viboquercitol with Acetobacter suboxydans. dl - 2,3,4,6 - Tetrahydroxy - cyclohexanone- (2,4,6-cis) is prepared by reducing dl-epiinosose with hydrogen and PtO 2 and oxidizing the resulting di-epi-quercitol with Acetobacter suboxydans, 2,4,5-Tri-hydroxycyclohexanone(2,4-cis) is prepared by treating 4-cyclohexene-1α,2#-diol with 3-chloroperbenzoic acid and heating the resulting 4,5-epoxycyclohexane-1α,2#-diol with BF 3 etherate. 2,5-Dideoxy-5-iodostreptamine is prepared by treating 2-deoxy-1,6 : 3,4-dicarbonylstreptamine with methanesulphonyl chloride, treating the resulting 5-O-methanesulphonyl derivative with Na1, refluxing the resulting 5-deoxy- 5-iodo derivative with HCl, treating the resulting 2,5-dideoxy-5-iodostreptamine dihydrochloride with acetic anhydride and sodium acetate and hydrolysing the resulting N,N1-diacetyl-2,5- dideoxy-5-iodo-streptamine with aqueous HCl. 2,5-Dideoxy-5-fluorostreptamine is prepared by heating 2-deoxy-5-O-methanesulphonyl-1,6 : 3,4-dicarbonylstreptamine with HCl, reacting the resulting 2-deoxy-5-O-methanesulphonylstreptamine dihydrochloride with aqueous NaOH and then benzyl chloroformate, treating the resulting N,N1- di - carbobenzoxy - 2 -deoxy - 5-O- methanesulphonylstreptamine with KF and hydrolysing the resulting N,N1-dicarbobenzoxy- 2,5-dideoxy-5-fluorostreptamine with aqueous mineral acid. Pharmaceutical compositions having antibacterial activity comprise, as active ingredient, an aminocyclitol antibiotic (I) or an acid addition salt thereof, together with a pharmaceutical carrier.

Claims (1)

PATENTKRAVPATENT REQUIREMENTS 1. Forfarande for framstallning av en aminocyklitol med formeln I: 6 5 - 112' HO van i R2 och vardera betecknar vAte eller hydroxi; och i nSrvaro av Micromonospora purpurea ATCC 31 164, att om sA 5nskas en erhAllen fOrening fAr reagera med en N-hydroxisuccinimidester med formeln IV: 0 CH2O-C-NRCH2(CH2)nCH0HCO-0-0 vari R1, R3 och R8 vardera betecknar :rate och R2 och R5 vardera betecknar vate eller hydroxi, R6 och R7 vardera betecknar vate eller metyl, kanntecknat darav, att ett naringsmedium innehallande kolhydrater, en kalla far assimilerbart kvave, esscntiella salter och en aminocyklitol med formeln Ha eller IIb: van i n betecknar noll eller 1, och att bensyloxikarbonylgruppen i den erhallna produkten underkastas hydrogenolys med vate aver en katalysator for framstallning av en farening, van i en av R1. R3 och 128 betecknar en ta-amino-0C-hydroxi-lagre-alkanoylgrupp, och att om sa beckon en erhallen-fri bas overfares till ett syraadditionssalt darav.A process for the preparation of an aminocyclitol of the formula I: wherein R 2 and each represents hydrogen or hydroxy; and in the presence of Micromonospora purpurea ATCC 31 164, that if desired an obtained compound is reacted with an N-hydroxysuccinimide ester of formula IV: CH 2 O-C-NRCH 2 (CH 2) n CHOHCO-0-O wherein R 1, R 3 and R 8 each represent : r and R 2 and R 5 each represent vate or hydroxy, R 6 and R 7 each represent vate or methyl, characterized in that a nutrient medium containing carbohydrates, a cold father assimilable nitrogen, essential salts and an aminocyclitol of formula Ha or IIb: van den zero or 1, and that the benzyloxycarbonyl group in the product obtained is subjected to hydrogenolysis with a catalyst for the preparation of a compound, one of R1. R 3 and 128 represent a ta-amino-OC-hydroxy-lower alkanoyl group, and if so beckon a residue-free base is transferred to an acid addition salt thereof.
SE8007540A 1975-02-18 1980-10-27 aminocyclitols SE8007540L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/550,273 US3972930A (en) 1975-02-18 1975-02-18 Aminocyclitol antibiotics
US05/615,593 US3982996A (en) 1975-09-22 1975-09-22 Process for preparing aminocyclitol antibiotics

Publications (1)

Publication Number Publication Date
SE8007540L true SE8007540L (en) 1980-10-27

Family

ID=27069389

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7601810A SE7601810L (en) 1975-02-18 1976-02-17 AMINOCYCLITOLANTIBIOTICS AND PROCEDURES FOR THE PREPARATION
SE8007540A SE8007540L (en) 1975-02-18 1980-10-27 aminocyclitols

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7601810A SE7601810L (en) 1975-02-18 1976-02-17 AMINOCYCLITOLANTIBIOTICS AND PROCEDURES FOR THE PREPARATION

Country Status (21)

Country Link
JP (1) JPS51108041A (en)
AR (3) AR221027A1 (en)
AU (1) AU503105B2 (en)
CA (1) CA1061731A (en)
CH (3) CH617964A5 (en)
DE (1) DE2606517A1 (en)
DK (1) DK143111C (en)
EG (1) EG12994A (en)
ES (1) ES445274A1 (en)
FI (1) FI56026C (en)
FR (1) FR2301265A1 (en)
GB (1) GB1529376A (en)
GR (1) GR60050B (en)
IE (1) IE42807B1 (en)
IL (1) IL49053A (en)
IN (2) IN147046B (en)
NL (1) NL7601655A (en)
NO (3) NO147308C (en)
NZ (1) NZ180036A (en)
PT (1) PT64816B (en)
SE (2) SE7601810L (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR955564A (en) * 1946-10-24 1950-01-17
AU2007255856B2 (en) 2006-06-02 2012-08-16 Meiji Seika Pharma Co., Ltd. Novel aminoglycoside antibiotic

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH606434A5 (en) * 1973-08-06 1978-10-31 Scherico Ltd

Also Published As

Publication number Publication date
EG12994A (en) 1980-07-31
CH618214A5 (en) 1980-07-15
AR227266A1 (en) 1982-10-15
NO147308C (en) 1983-03-16
DE2606517A1 (en) 1976-08-26
AU503105B2 (en) 1979-08-23
JPS51108041A (en) 1976-09-25
CA1061731A (en) 1979-09-04
FI760387A (en) 1976-08-19
DK143111C (en) 1981-11-16
NO146811B (en) 1982-09-06
PT64816A (en) 1976-03-01
FI56026B (en) 1979-07-31
IE42807L (en) 1976-08-18
PT64816B (en) 1978-07-03
NO803185L (en) 1976-08-19
NO148298B (en) 1983-06-06
AR217417A1 (en) 1980-03-31
DK143111B (en) 1981-03-30
IE42807B1 (en) 1980-10-22
ES445274A1 (en) 1977-06-16
DK63176A (en) 1976-08-19
AR221027A1 (en) 1980-12-30
IN149240B (en) 1981-10-10
SE7601810L (en) 1976-08-19
NO760472L (en) 1976-08-19
NZ180036A (en) 1979-10-25
NO146811C (en) 1982-12-15
IL49053A (en) 1979-11-30
IN147046B (en) 1979-10-27
CH618215A5 (en) 1980-07-15
NO820574L (en) 1976-08-19
FR2301265B1 (en) 1979-05-25
FR2301265A1 (en) 1976-09-17
GB1529376A (en) 1978-10-18
GR60050B (en) 1978-04-04
NO148298C (en) 1983-09-14
FI56026C (en) 1979-11-12
AU1117776A (en) 1977-08-25
IL49053A0 (en) 1976-04-30
NO147308B (en) 1982-12-06
CH617964A5 (en) 1980-06-30
NL7601655A (en) 1976-08-20

Similar Documents

Publication Publication Date Title
IE68420B1 (en) Amide derivatives of antibiotic A 40926
US4123539A (en) 6-Ethylpenicillanic acid
SE8007540L (en) aminocyclitols
HU198507B (en) Process for producing metal complexes of 11-aza-10-deoxo-10-dihydro-erythromycin-a derivatives and pharmaceutical compositions comprising these compouharmaceutical nds as active ingredient
Yonehara et al. The detoxin complex, selective antagonists of blasticidin S
KR890005139A (en) Teicoplanin-like derivatives
US3869445A (en) 4{41 -O-sulfonyl erythromycin-9-O-oxime derivatives
US4396609A (en) Aminocyclitol antibiotics, pharmaceutical compositions and method of using same
GB1509802A (en) Aminoglycoside derivatives
IL41937A (en) 6-(2-phenyl-2-guanylureido-substituted acetamido)penicillanic acids their preparation and pharmaceutical compositions containing them
US4786723A (en) 7-hydroxyguanine compounds, process for preparing said compounds, and anti-tumor agent containing the same
HUT46945A (en) Process for producing new azoxy derivatives and pharmaceutical compositions containing them as active components
GB1481529A (en) Cephalosporin antibiotic substance and the production thereof
US4217446A (en) ωAmino-2-hydroxyalkyl derivatives of aminoglycoside antibiotics
CA2047997C (en) Antibiotic, balhimycin, a process for its production and its use as pharmaceutical
GB1462805A (en) Antibiotic and process for the preparation thereof
GB1500965A (en) Cyclic ether antibiotics
US3907774A (en) Celestosaminide antibiotic derivatives
GB1479179A (en) Antibiotics designated xk-88 series and process for production thereof
GB8802229D0 (en) Ws-9326 & its derivatives
GB1455128A (en) Purpuromycin and its derivatives
US3207750A (en) Derivatives of decoyinine
GB1460811A (en) Bis-benzamido-benzoic acid derivatives
US3619374A (en) Antibiotic production utilizing streptomyces refuineus var. thermotolerans
US3819600A (en) Alpha-carboxamido acyl derivatives of penicillin

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8007540-1